Click for best price
Oral Antidiabetic Drugs Market Size, Share 2022
Market Analysis and Insights: Global Oral Antidiabetic Drugs Market
The global Oral Antidiabetic Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Oral Antidiabetic Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Oral Antidiabetic Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Oral Antidiabetic Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Oral Antidiabetic Drugs market.
Global Oral Antidiabetic Drugs Scope and Market Size
Oral Antidiabetic Drugs market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Oral Antidiabetic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Oral Antidiabetic Drugs market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Sulfonylureas
Meglitinides
Alpha-glucosidase inhibitors
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Eli Lilly
Abbott
Biocon
Sanofi
Sunpharma
Novartis
Novo Nordisk
Merck
Pfizer
Huadong Medicine Co.,Ltd.
Lepu Medical
Hengrui Medicine
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Oral Antidiabetic Drugs product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Oral Antidiabetic Drugs, with price, sales, revenue, and global market share of Oral Antidiabetic Drugs from 2019 to 2022.
Chapter 3, the Oral Antidiabetic Drugs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Antidiabetic Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Oral Antidiabetic Drugs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oral Antidiabetic Drugs.
Chapter 13, 14, and 15, to describe Oral Antidiabetic Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Oral Antidiabetic Drugs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global and United States Oral Antidiabetic Drugs Market Report & Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
102 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Oral Antidiabetic Drugs Product Introduction
1.2 Global Oral Antidiabetic Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Oral Antidiabetic Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Oral Antidiabetic Drugs Sales in Volume for the Year 2017-2028
1.3 United States Oral Antidiabetic Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Oral Antidiabetic Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Oral Antidiabetic Drugs Sales in Volume for the Year 2017-2028
1.4 Oral Antidiabetic Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Oral Antidiabetic Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Oral Antidiabetic Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Oral Antidiabetic Drugs Market Dynamics
1.5.1 Oral Antidiabetic Drugs Industry Trends
1.5.2 Oral Antidiabetic Drugs Market Drivers
1.5.3 Oral Antidiabetic Drugs Market Challenges
1.5.4 Oral Antidiabetic Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Oral Antidiabetic Drugs Market Segment by Type
2.1.1 Sulfonylureas
2.1.2 Meglitinides
2.1.3 Alpha-glucosidase inhibitors
2.2 Global Oral Antidiabetic Drugs Market Size by Type
2.2.1 Global Oral Antidiabetic Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Oral Antidiabetic Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Oral Antidiabetic Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Oral Antidiabetic Drugs Market Size by Type
2.3.1 United States Oral Antidiabetic Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Oral Antidiabetic Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Oral Antidiabetic Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Oral Antidiabetic Drugs Market Segment by Application
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Oral Antidiabetic Drugs Market Size by Application
3.2.1 Global Oral Antidiabetic Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Oral Antidiabetic Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Oral Antidiabetic Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Oral Antidiabetic Drugs Market Size by Application
3.3.1 United States Oral Antidiabetic Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Oral Antidiabetic Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Oral Antidiabetic Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Oral Antidiabetic Drugs Competitor Landscape by Company
4.1 Global Oral Antidiabetic Drugs Market Size by Company
4.1.1 Top Global Oral Antidiabetic Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Oral Antidiabetic Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Oral Antidiabetic Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Oral Antidiabetic Drugs Price by Manufacturer (2017-2022)
4.2 Global Oral Antidiabetic Drugs Concentration Ratio (CR)
4.2.1 Oral Antidiabetic Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Oral Antidiabetic Drugs in 2021
4.2.3 Global Oral Antidiabetic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Oral Antidiabetic Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Oral Antidiabetic Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Oral Antidiabetic Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Oral Antidiabetic Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Oral Antidiabetic Drugs Market Size by Company
4.5.1 Top Oral Antidiabetic Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Oral Antidiabetic Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Oral Antidiabetic Drugs Sales by Players (2020, 2021 & 2022)
5 Global Oral Antidiabetic Drugs Market Size by Region
5.1 Global Oral Antidiabetic Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Oral Antidiabetic Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Oral Antidiabetic Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Oral Antidiabetic Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Oral Antidiabetic Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Oral Antidiabetic Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Oral Antidiabetic Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Oral Antidiabetic Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Oral Antidiabetic Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 United States
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Oral Antidiabetic Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Oral Antidiabetic Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Oral Antidiabetic Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Oral Antidiabetic Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Oral Antidiabetic Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Oral Antidiabetic Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Oral Antidiabetic Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Oral Antidiabetic Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Eli Lilly
7.1.1 Eli Lilly Corporation Information
7.1.2 Eli Lilly Description and Business Overview
7.1.3 Eli Lilly Oral Antidiabetic Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Eli Lilly Oral Antidiabetic Drugs Products Offered
7.1.5 Eli Lilly Recent Development
7.2 Abbott
7.2.1 Abbott Corporation Information
7.2.2 Abbott Description and Business Overview
7.2.3 Abbott Oral Antidiabetic Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Abbott Oral Antidiabetic Drugs Products Offered
7.2.5 Abbott Recent Development
7.3 Biocon
7.3.1 Biocon Corporation Information
7.3.2 Biocon Description and Business Overview
7.3.3 Biocon Oral Antidiabetic Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Biocon Oral Antidiabetic Drugs Products Offered
7.3.5 Biocon Recent Development
7.4 Sanofi
7.4.1 Sanofi Corporation Information
7.4.2 Sanofi Description and Business Overview
7.4.3 Sanofi Oral Antidiabetic Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Sanofi Oral Antidiabetic Drugs Products Offered
7.4.5 Sanofi Recent Development
7.5 Sunpharma
7.5.1 Sunpharma Corporation Information
7.5.2 Sunpharma Description and Business Overview
7.5.3 Sunpharma Oral Antidiabetic Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Sunpharma Oral Antidiabetic Drugs Products Offered
7.5.5 Sunpharma Recent Development
7.6 Novartis
7.6.1 Novartis Corporation Information
7.6.2 Novartis Description and Business Overview
7.6.3 Novartis Oral Antidiabetic Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Novartis Oral Antidiabetic Drugs Products Offered
7.6.5 Novartis Recent Development
7.7 Novo Nordisk
7.7.1 Novo Nordisk Corporation Information
7.7.2 Novo Nordisk Description and Business Overview
7.7.3 Novo Nordisk Oral Antidiabetic Drugs Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Novo Nordisk Oral Antidiabetic Drugs Products Offered
7.7.5 Novo Nordisk Recent Development
7.8 Merck
7.8.1 Merck Corporation Information
7.8.2 Merck Description and Business Overview
7.8.3 Merck Oral Antidiabetic Drugs Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Merck Oral Antidiabetic Drugs Products Offered
7.8.5 Merck Recent Development
7.9 Pfizer
7.9.1 Pfizer Corporation Information
7.9.2 Pfizer Description and Business Overview
7.9.3 Pfizer Oral Antidiabetic Drugs Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Pfizer Oral Antidiabetic Drugs Products Offered
7.9.5 Pfizer Recent Development
7.10 Huadong Medicine Co.,Ltd.
7.10.1 Huadong Medicine Co.,Ltd. Corporation Information
7.10.2 Huadong Medicine Co.,Ltd. Description and Business Overview
7.10.3 Huadong Medicine Co.,Ltd. Oral Antidiabetic Drugs Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Huadong Medicine Co.,Ltd. Oral Antidiabetic Drugs Products Offered
7.10.5 Huadong Medicine Co.,Ltd. Recent Development
7.11 Lepu Medical
7.11.1 Lepu Medical Corporation Information
7.11.2 Lepu Medical Description and Business Overview
7.11.3 Lepu Medical Oral Antidiabetic Drugs Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Lepu Medical Oral Antidiabetic Drugs Products Offered
7.11.5 Lepu Medical Recent Development
7.12 Hengrui Medicine
7.12.1 Hengrui Medicine Corporation Information
7.12.2 Hengrui Medicine Description and Business Overview
7.12.3 Hengrui Medicine Oral Antidiabetic Drugs Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Hengrui Medicine Products Offered
7.12.5 Hengrui Medicine Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Oral Antidiabetic Drugs Industry Chain Analysis
8.2 Oral Antidiabetic Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Oral Antidiabetic Drugs Distributors
8.3 Oral Antidiabetic Drugs Production Mode & Process
8.4 Oral Antidiabetic Drugs Sales and Marketing
8.4.1 Oral Antidiabetic Drugs Sales Channels
8.4.2 Oral Antidiabetic Drugs Distributors
8.5 Oral Antidiabetic Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Oral Antidiabetic Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Oral Antidiabetic Drugs Market Trends
Table 3. Oral Antidiabetic Drugs Market Drivers
Table 4. Oral Antidiabetic Drugs Market Challenges
Table 5. Oral Antidiabetic Drugs Market Restraints
Table 6. Global Oral Antidiabetic Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Oral Antidiabetic Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Oral Antidiabetic Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Oral Antidiabetic Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Oral Antidiabetic Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Oral Antidiabetic Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Oral Antidiabetic Drugs Revenue Share by Manufacturer, 2017-2022
Table 13. Global Oral Antidiabetic Drugs Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global Oral Antidiabetic Drugs Sales Share by Manufacturer, 2017-2022
Table 15. Global Oral Antidiabetic Drugs Price by Manufacturer (2017-2022) & (US$/Unit)
Table 16. Global Oral Antidiabetic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Oral Antidiabetic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Antidiabetic Drugs as of 2021)
Table 18. Top Players of Oral Antidiabetic Drugs in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Oral Antidiabetic Drugs Product Type
Table 20. Date of International Manufacturers Enter into Oral Antidiabetic Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Oral Antidiabetic Drugs Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Oral Antidiabetic Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Oral Antidiabetic Drugs Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Oral Antidiabetic Drugs Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States Oral Antidiabetic Drugs Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Oral Antidiabetic Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Oral Antidiabetic Drugs Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global Oral Antidiabetic Drugs Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global Oral Antidiabetic Drugs Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Oral Antidiabetic Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Oral Antidiabetic Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America Oral Antidiabetic Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Oral Antidiabetic Drugs Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific Oral Antidiabetic Drugs Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Oral Antidiabetic Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe Oral Antidiabetic Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Oral Antidiabetic Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa Oral Antidiabetic Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Oral Antidiabetic Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa Oral Antidiabetic Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Eli Lilly Corporation Information
Table 43. Eli Lilly Description and Business Overview
Table 44. Eli Lilly Oral Antidiabetic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 45. Eli Lilly Oral Antidiabetic Drugs Product
Table 46. Eli Lilly Recent Development
Table 47. Abbott Corporation Information
Table 48. Abbott Description and Business Overview
Table 49. Abbott Oral Antidiabetic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 50. Abbott Product
Table 51. Abbott Recent Development
Table 52. Biocon Corporation Information
Table 53. Biocon Description and Business Overview
Table 54. Biocon Oral Antidiabetic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 55. Biocon Product
Table 56. Biocon Recent Development
Table 57. Sanofi Corporation Information
Table 58. Sanofi Description and Business Overview
Table 59. Sanofi Oral Antidiabetic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 60. Sanofi Product
Table 61. Sanofi Recent Development
Table 62. Sunpharma Corporation Information
Table 63. Sunpharma Description and Business Overview
Table 64. Sunpharma Oral Antidiabetic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 65. Sunpharma Product
Table 66. Sunpharma Recent Development
Table 67. Novartis Corporation Information
Table 68. Novartis Description and Business Overview
Table 69. Novartis Oral Antidiabetic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 70. Novartis Product
Table 71. Novartis Recent Development
Table 72. Novo Nordisk Corporation Information
Table 73. Novo Nordisk Description and Business Overview
Table 74. Novo Nordisk Oral Antidiabetic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 75. Novo Nordisk Product
Table 76. Novo Nordisk Recent Development
Table 77. Merck Corporation Information
Table 78. Merck Description and Business Overview
Table 79. Merck Oral Antidiabetic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 80. Merck Product
Table 81. Merck Recent Development
Table 82. Pfizer Corporation Information
Table 83. Pfizer Description and Business Overview
Table 84. Pfizer Oral Antidiabetic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 85. Pfizer Product
Table 86. Pfizer Recent Development
Table 87. Huadong Medicine Co.,Ltd. Corporation Information
Table 88. Huadong Medicine Co.,Ltd. Description and Business Overview
Table 89. Huadong Medicine Co.,Ltd. Oral Antidiabetic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 90. Huadong Medicine Co.,Ltd. Product
Table 91. Huadong Medicine Co.,Ltd. Recent Development
Table 92. Lepu Medical Corporation Information
Table 93. Lepu Medical Description and Business Overview
Table 94. Lepu Medical Oral Antidiabetic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 95. Lepu Medical Product
Table 96. Lepu Medical Recent Development
Table 97. Hengrui Medicine Corporation Information
Table 98. Hengrui Medicine Description and Business Overview
Table 99. Hengrui Medicine Oral Antidiabetic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 100. Hengrui Medicine Product
Table 101. Hengrui Medicine Recent Development
Table 102. Key Raw Materials Lists
Table 103. Raw Materials Key Suppliers Lists
Table 104. Oral Antidiabetic Drugs Customers List
Table 105. Oral Antidiabetic Drugs Distributors List
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Antidiabetic Drugs Product Picture
Figure 2. Global Oral Antidiabetic Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Oral Antidiabetic Drugs Market Size 2017-2028 (US$ Million)
Figure 4. Global Oral Antidiabetic Drugs Sales 2017-2028 (K Units)
Figure 5. United States Oral Antidiabetic Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Oral Antidiabetic Drugs Market Size 2017-2028 (US$ Million)
Figure 7. United States Oral Antidiabetic Drugs Sales 2017-2028 (K Units)
Figure 8. United States Oral Antidiabetic Drugs Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Oral Antidiabetic Drugs Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. Oral Antidiabetic Drugs Report Years Considered
Figure 11. Product Picture of Sulfonylureas
Figure 12. Product Picture of Meglitinides
Figure 13. Product Picture of Alpha-glucosidase inhibitors
Figure 14. Global Oral Antidiabetic Drugs Market Share by Type in 2022 & 2028
Figure 15. Global Oral Antidiabetic Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 16. Global Oral Antidiabetic Drugs Sales Market Share in Value by Type (2017-2028)
Figure 17. Global Oral Antidiabetic Drugs Sales by Type (2017-2028) & (K Units)
Figure 18. Global Oral Antidiabetic Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 19. Global Oral Antidiabetic Drugs Price by Type (2017-2028) & (US$/Unit)
Figure 20. United States Oral Antidiabetic Drugs Market Share by Type in 2022 & 2028
Figure 21. United States Oral Antidiabetic Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 22. United States Oral Antidiabetic Drugs Sales Market Share in Value by Type (2017-2028)
Figure 23. United States Oral Antidiabetic Drugs Sales by Type (2017-2028) & (K Units)
Figure 24. United States Oral Antidiabetic Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 25. United States Oral Antidiabetic Drugs Price by Type (2017-2028) & (US$/Unit)
Figure 26. Product Picture of Hospitals
Figure 27. Product Picture of Clinics
Figure 28. Product Picture of Others
Figure 29. Global Oral Antidiabetic Drugs Market Share by Application in 2022 & 2028
Figure 30. Global Oral Antidiabetic Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 31. Global Oral Antidiabetic Drugs Sales Market Share in Value by Application (2017-2028)
Figure 32. Global Oral Antidiabetic Drugs Sales by Application (2017-2028) & (K Units)
Figure 33. Global Oral Antidiabetic Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 34. Global Oral Antidiabetic Drugs Price by Application (2017-2028) & (US$/Unit)
Figure 35. United States Oral Antidiabetic Drugs Market Share by Application in 2022 & 2028
Figure 36. United States Oral Antidiabetic Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 37. United States Oral Antidiabetic Drugs Sales Market Share in Value by Application (2017-2028)
Figure 38. United States Oral Antidiabetic Drugs Sales by Application (2017-2028) & (K Units)
Figure 39. United States Oral Antidiabetic Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 40. United States Oral Antidiabetic Drugs Price by Application (2017-2028) & (US$/Unit)
Figure 41. North America Oral Antidiabetic Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 42. North America Oral Antidiabetic Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 43. United States Oral Antidiabetic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Canada Oral Antidiabetic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Europe Oral Antidiabetic Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 46. Europe Oral Antidiabetic Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 47. Germany Oral Antidiabetic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. France Oral Antidiabetic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. U.K. Oral Antidiabetic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Italy Oral Antidiabetic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Russia Oral Antidiabetic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Asia-Pacific Oral Antidiabetic Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 53. Asia-Pacific Oral Antidiabetic Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 54. China Oral Antidiabetic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Japan Oral Antidiabetic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. South Korea Oral Antidiabetic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. India Oral Antidiabetic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Australia Oral Antidiabetic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. China Taiwan Oral Antidiabetic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Indonesia Oral Antidiabetic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Thailand Oral Antidiabetic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Malaysia Oral Antidiabetic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Latin America Oral Antidiabetic Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 64. Latin America Oral Antidiabetic Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 65. Mexico Oral Antidiabetic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Brazil Oral Antidiabetic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Argentina Oral Antidiabetic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Middle East & Africa Oral Antidiabetic Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 69. Middle East & Africa Oral Antidiabetic Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 70. Turkey Oral Antidiabetic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Saudi Arabia Oral Antidiabetic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. UAE Oral Antidiabetic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Oral Antidiabetic Drugs Value Chain
Figure 74. Oral Antidiabetic Drugs Production Process
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
